Igg Like Bispecific Antibody

Anti-CD20-Anti-CD3 Bispecific Antibody

100836-1 50 µg
EUR 370
Description: Anti-CD20-Anti-CD3 Fc format bispecific antibody is a purified recombinant human bispecific antibody with T cell Engager. This bispecific antibody has been tested for specific activity in the functional reporter assay using NFAT-luc reporter Jurkat cell line (BPS Bioscience #60621) in the presence of CD20-CHO cells (BPS Bioscience #79624-H).

Igg Antibody Laboratories manufactures the igg like bispecific antibody reagents distributed by Genprice. The Igg Like Bispecific Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igg antibody. Other Igg products are available in stock. Specificity: Igg Category: Like Group: Bispecific Antibody

True Blue

5mg Ask for price
Description: True Blue

JBS True Blue

300 µl
EUR 16
Description: JBS True Blue

JBS True Blue

300µl
EUR 13.7

Anti-CD19-Anti-CD3 Bispecific Antibody (50 µg)

50 µg
EUR 390
Description: Anti-CD19-Anti-CD3-His-Tag is a purified recombinant human bispecific T cell Engager (BiTE) based on Amgen's Blinatumomab. This BiTE has been tested for specific activity in both ELISA binding assay to CD19-biotin and functional reporter assays using Jurkat/NFAT-luc or Jurkat/IL2-Luc reporter cell lines in the presence of CD19+ Raji cells.

Anti-CD19-Anti-CD3 Bispecific Antibody (100 µg)

100 µg
EUR 535
Description: Anti-CD19-Anti-CD3-His-Tag is a purified recombinant human bispecific T cell Engager (BiTE) based on Amgen's Blinatumomab. This BiTE has been tested for specific activity in both ELISA binding assay to CD19-biotin and functional reporter assays using Jurkat/NFAT-luc or Jurkat/IL2-Luc reporter cell lines in the presence of CD19+ Raji cells.

Anti-PSMA-Anti-CD3 IgG format Bispecific Antibody

50 µg
EUR 390
Description: Anti-PSMA-Anti-CD3 IgG format bispecific antibody is a purified recombinant human bispecific antibody with T cell Engager. This bispecific antibody has been tested for specific activity in the functional reporter assay using NFAT-luc reporter Jurkat cell line (BPS Bioscience #60621) in the presence of PSMA-CHO cells (BPS Bioscience #79641-H).PSMA (Prostate-Specific Membrane antigen), also known as FLOH1 (folate hydrolase 1) and NAALADase I (N-acetyl-L-aspartyl-L-glutamate peptidase I) is a transmembrane protein highly expressed in the intestine, the prostate, and the nervous system. The protein is a glutamate carboxypeptidase involved in folate metabolism and may be involved in pathological conditions such as hyperhomocysteinemia (intestine) and glutamate toxicity (nervous system). PSMA is overexpressed in prostate cancer cells and is the target of an increasing number of diagnostic and therapeutic approaches used for the treatment of prostate cancer.

Anti-PSMA-Anti-CD3 IgG format Bispecific Antibody

100 µg
EUR 490
Description: Anti-PSMA-Anti-CD3 IgG format bispecific antibody is a purified recombinant human bispecific antibody with T cell Engager. This bispecific antibody has been tested for specific activity in the functional reporter assay using NFAT-luc reporter Jurkat cell line (BPS Bioscience #60621) in the presence of PSMA-CHO cells (BPS Bioscience #79641-H).PSMA (Prostate-Specific Membrane antigen), also known as FLOH1 (folate hydrolase 1) and NAALADase I (N-acetyl-L-aspartyl-L-glutamate peptidase I) is a transmembrane protein highly expressed in the intestine, the prostate, and the nervous system. The protein is a glutamate carboxypeptidase involved in folate metabolism and may be involved in pathological conditions such as hyperhomocysteinemia (intestine) and glutamate toxicity (nervous system). PSMA is overexpressed in prostate cancer cells and is the target of an increasing number of diagnostic and therapeutic approaches used for the treatment of prostate cancer.

Bispecific Antibody information

Recombinant Anti-EGFR x Anti-HER3 Bispecific Antibody (DART)

DART-156 200μg Ask for price
Description: A bispecific antibody that is expressed as two polypeptide chains respectively, and a disulfide bond is introduced into the chains. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Solid tumors therapy.

Recombinant Anti-CD8 x Anti-PSCA Bispecific Antibody (TandAb)

TANDAB-131 200μg Ask for price
Description: A bispecific antibody that is expressed as a monomeric subunit (single chain Diabody, scDb), with four variable domains from two parental antibodies. Then the two peptide chains can dimerize in a head-to-tail fashion. This BsAb can retarget T cells to tumor cells. It is designed for the research of Prostate cancer therapy.

Recombinant Anti-CD3 x Anti-CEA Bispecific Antibody (CrossMab)

CROSSAB-072 200μg Ask for price
Description: A bispecific antibody that is expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can retarget T cells to tumor cells. It is designed for the research of Colorectal cancer (CRC); Breast cancer; Lung cancer; Gastric cancer therapy.

Recombinant Anti-CD3 x Anti-FAP Bispecific Antibody (CrossMab)

CROSSAB-080 200μg Ask for price
Description: A bispecific antibody that is expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can retarget T cells to tumor cells. It is designed for the research of Epithelial cancers therapy.

Recombinant Anti-CD3 x Anti-EPCAM Bispecific Antibody (CrossMab)

CROSSAB-079 200μg Ask for price
Description: A bispecific antibody that is expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can retarget T cells to tumor cells. It is designed for the research of Solid tumors therapy.

Recombinant Anti-HER2 x Anti-HER3 Bispecific Antibody (Diabody)

BSDB-167 200μg Ask for price
Description: A bispecific antibody that is expressed as two polypeptide chains respectively. The two chains are cross-over pairing to form a dimer. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors therapy.

Recombinant Anti-TfR x Anti-Aβ Bispecific Antibody (Triple Body)

TRIB-356-100ug 100μg
EUR 4833.6
Description: A bispecific antibody that is expressed as two polypeptide chains respectively. The Fd fragment and LC from one antibody are both extended with the scFv fragment from the other antibody. This BsAb can deliver the anti-Aβ antibody cross the blood-brain barrier (BBB). It is designed for the research of Alzheimer's disease therapy.

Recombinant Anti-TfR x Anti-Aβ Bispecific Antibody (Triple Body)

TRIB-356-50ug 50μg
EUR 3008.4
Description: A bispecific antibody that is expressed as two polypeptide chains respectively. The Fd fragment and LC from one antibody are both extended with the scFv fragment from the other antibody. This BsAb can deliver the anti-Aβ antibody cross the blood-brain barrier (BBB). It is designed for the research of Alzheimer's disease therapy.

Recombinant Anti-BSA x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-c001-100ug 100μg
EUR 4552.8
Description: A bispecific antibody that is expressed as an anti-BSA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can be used as a negative control to other anti-CD3 BsAbs in the research of tumor therapy.

Recombinant Anti-BSA x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-c001-50ug 50μg
EUR 2587.2
Description: A bispecific antibody that is expressed as an anti-BSA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can be used as a negative control to other anti-CD3 BsAbs in the research of tumor therapy.

Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem Fab)

BSFAB-046-100ug 100μg
EUR 4693.2
Description: A bispecific antibody that is expressed as an anti-CD2 Fd region fused to an anti-EGFR Fd region. The two Fd regions are connected by a flexible linker. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.

Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem Fab)

BSFAB-046-50ug 50μg
EUR 2868
Description: A bispecific antibody that is expressed as an anti-CD2 Fd region fused to an anti-EGFR Fd region. The two Fd regions are connected by a flexible linker. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.

Recombinant Anti-CD3 x Anti-CEA Bispecific Antibody (Tandem scFv)

BSFV-072-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-CEA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Colorectal cancer (CRC); Breast cancer; Lung cancer; Gastric cancer therapy.

Recombinant Anti-CD3 x Anti-CEA Bispecific Antibody (Tandem scFv)

BSFV-072-50ug 50μg
EUR 2446.8
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-CEA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Colorectal cancer (CRC); Breast cancer; Lung cancer; Gastric cancer therapy.

Recombinant Anti-FIXa x Anti-FX Bispecific Antibody (Tandem scFv)

BSFV-162-100ug 100μg
EUR 4552.8
Description: A bispecific antibody that is expressed as an anti-FIXa scFv fused with an anti-FX scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can bind and dimerize two factors. It acts as mimetic FXIII. It is designed for the research of Hemophilia A therapy.

Recombinant Anti-FIXa x Anti-FX Bispecific Antibody (Tandem scFv)

BSFV-162-50ug 50μg
EUR 2587.2
Description: A bispecific antibody that is expressed as an anti-FIXa scFv fused with an anti-FX scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can bind and dimerize two factors. It acts as mimetic FXIII. It is designed for the research of Hemophilia A therapy.

Recombinant Anti-BCMA x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-020-100ug 100μg
EUR 4272
Description: A bispecific antibody that is expressed as an anti-BCMA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Multiple myeloma (MM) therapy.